Biodesix

$2.65 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Biodesix

Biodesix, Inc. operates as a biotechnology company. The Company offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue analysis in the United States.

Stock Analysis

last close $2.61
1-mo return 41.1%
3-mo return 62.6%
avg daily vol. 118.91T
52-week high 10.22
52-week low 1.25
market cap. $104M
forward pe -
annual div. -
roe -336%
ltg forecast -
dividend yield -
annual rev. $31M
inst own. 10.3%
baraka

Subscribe now for daily local and international financial news

Subscribe